# Tegoprazan-containing Sequential for H. Pylori

> **NCT06382493** · NA · RECRUITING · sponsor: **Seoul National University Bundang Hospital** · enrollment: 400 (estimated)

## Conditions studied

- Helicobacter Pylori Infection

## Interventions

- **DRUG:** Tegoprazan-containing sequential H. pylori eradication therapy
- **DRUG:** Esomeprazole-containing sequential H. pylori eradication therapy

## Key facts

- **NCT ID:** NCT06382493
- **Lead sponsor:** Seoul National University Bundang Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-02-01
- **Primary completion:** 2026-12-12
- **Final completion:** 2026-12-12
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2026-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06382493

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06382493, "Tegoprazan-containing Sequential for H. Pylori". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT06382493. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*